Boston Scientific Corp. (NYSE:BSX)

255. Boston Scientific (NYSE: BSX) is bottoming. Target: $6-$7. Now is a good time to buy. I'll be voting on this with my caps points. Sure, it is cheap and it lacks catalysts. At this point, the catalyst is effectively a rhetorical question: "who is going to sell?" Since stock prices are a function of daily supply and demand, I expect that the lack of selling at these prices and the bottoming effect will drive the stock into my price range. Eventually, at prices low enough, investors kind of look around at each other and decide that selling doesn't make sense. At that point, you don't need catalysts for upside because you get a self-fulfilling bottoming prophecy that does it on its own.

http://beta.fool.com/bradford86/2012/01/10/price-market-part-37/

Positive:
- New management
- Finally at 15 year lows insiders start buying
- Debt goes down
- And yes, they still have a pipeline which might come up with new innovations
- Short term oversold

Negative:
- Chart in a clean downtrend channel
- In the long-run health care costs have to go down because they can not be paid for but this might still be some years into the future
- Still not really cheap, but a defensive play which might work in the current environment

Category: MT+